Projects per year
Organization profile
Organisation profile
The research proup HEIM is part of the departement IMMI and centers its activity on the biology and treatment of haematological diseases. This activity is spread over the departments of Clinical Haematology and Stem Cell Transplantation (AZ VUB), Clinical Laboratory of Haematology and Immunology (AZ VUB), Blood Transfusion Centre Jette (Red Cross) and the basic research laboratory HEIM at the faculty of medicine. Following specific subjects are under study: 1. Biology of multiple myeloma and related diseases; 2. Molecular and phenotypic follow-up of B cell malignancies during therapy; 3. Stem cell processing and clinical transplantation; 4. Analysis of phenotype of haemopoietic stem cells in health and disease; 5. Homing of mesenchymal stem cell in bone marrow 5. MHC dysregulation in haematological malignancies; 6. Molecular analysis of antithrombine deficiency.
Fingerprint
Dive into the research topics where Hematology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Marleen Bakkus
- UZBrussel
- Vrije Universiteit Brussel
- Clinical Biology - UZB Researcher
- Hematology
Person: Researcher
-
Veerle Beckers
- UZBrussel
- Vrije Universiteit Brussel
- Hematology
- Hematology - UZB Physician
Person: Researcher, Physician
-
Nathan De Beule
- UZBrussel
- Vrije Universiteit Brussel
- Clinical sciences - Academic
- Hematology - UZB Physician
- Hematology
Person: Researcher, Physician
-
Wouter De Brouwer
- UZBrussel
- Vrije Universiteit Brussel
- Hematology
- Basic (bio-) Medical Sciences - Academic
- Hematology - UZB Physician
- Faculty of Medicine and Pharmacy
Person: Researcher, Physician, PhD, Advanced Master's Programme
-
OZR3740: Bilateral cooperation within the framework of a joint doctoral project: benchfee for joint PhD VUB - KU Leuven, DE COSTER Michiel
22/10/20 → 21/10/24
Project: Fundamental
-
FWOTM1002: Development of innovative NANObody-based therapies to eradicate REsidual disease in Multiple Myeloma (acronym: NANOREMM)
1/10/20 → 30/09/23
Project: Fundamental
-
FWOTM900: Modulating epigenetic mechanisms to enhance cancer immunotherapy.
Breckpot, K., De Beck, L. & Maes, K.
1/10/18 → 30/09/22
Project: Fundamental
-
OZR3286: Bilateral cooperation within the framework of a joint doctoral project: Bench Fee for Joint PhD VUB-UGent, Vlummens Philip
13/02/18 → 31/12/22
Project: Fundamental
Research output
-
Antithrombin p.Thr147Ala: The First Founder Mutation in People of African Origin Responsible for Inherited Antithrombin Deficiency
Orlando, C., de la Morena-Barrio, B., Pareyn, I., Vanhoorelbeke, K., Martínez-Martínez, I., Vicente, V., Corral, J., Jochmans, K. & de la Morena-Barrio, M. E., 1 Feb 2021, In : Thrombosis and Haemostasis. 121, 2, p. 182-191 10 p.Research output: Contribution to journal › Article
1 Citation (Scopus) -
A pilot study on the impact of congenital thrombophilia in COVID-19
de la Morena-Barrio, M. E., Bravo-Pérez, C., de la Morena-Barrio, B., Orlando, C., Cifuentes, R., Padilla, J., Miñano, A., Herrero, S., Marcellini, S., Revilla, N., Bernal, E., Gómez-Verdú, J. M., Jochmans, K., Herranz, M. T., Vicente, V., Corral, J. & Lozano, M. L., May 2021, In : European Journal of Clinical Investigation. 51, 5, 8 p., e13546.Research output: Contribution to journal › Article
1 Citation (Scopus) -
Combining dual G9a/DNMTs epigenetic inhibition and immunotherapy to treat metastatic melanoma
De Beck, L., Awad, R. M., De Vlaeminck, Y., Basso, V., Casares, N., Verhulst, S., San José-Enériz, E., De Ridder, K., Goyvaerts, C., Maes, K., Vanderkerken, K., Agirre, X., Prosper, F., Lasarte, J. J., Mondino, A. & Breckpot, K., 11 Feb 2021.Research output: Unpublished contribution to conference › Other
-
Dialyzer Performance During Hemodialysis Without Systemic Anticoagulation Using a Heparin-Grafted Dialyzer Combined With a Citrate-Enriched Dialysate: Results of the Randomized Crossover Noninferiority EVOCIT Study
François, K., De Clerck, D., Tonnelier, A., Cambier, M-L., Orlando, C., Jochmans, K., Cools, W. & Wissing, K. M., 30 Apr 2021, In : American Journal of Kidney Diseases.Research output: Contribution to journal › Article
-
Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential
Maes, K., Mondino, A., Lasarte, J. J., Agirre, X., Vanderkerken, K., Prosper, F. & Breckpot, K., 30 Mar 2021, In : Frontiers in Immunology. 12, 24 p., 652160.Research output: Contribution to journal › Article
Open AccessFile1 Citation (Scopus)3 Downloads (Pure)
Activities
-
LSM PHD DAY
Margo Willems (Chair), Wout De Mey (Chair), Axelle Cooreman (Organiser), Michiel De Coster (Organiser), Hamide Yildirim (Organiser), Catharina Muylaert (Organiser)31 Mar 2021Activity: Participating in or organising an event › Participation in workshop, seminar
-
LSM PhD day 2021
Michiel De Coster (Organiser)30 Mar 2021Activity: Participating in or organising an event › Participating in or organizing a school event
-
Spring Meeting Molecular Diagnostics 2021
Simke Demeester (Participant)1 Jun 2021Activity: Participating in or organising an event › Participation in conference
-
21st Annual Meeting of the Belgium Society for Human Genetics
Maria Filomena Cuevas Y Bretones (Organiser), Karen Sermon (Member of programme committee), Thomy de Ravel (Member of programme committee), Willem Verpoest (Member of programme committee), Catharina Olsen (Member of programme committee), Hilde Van De Velde (Member of programme committee), Freya Vaeyens (Member of programme committee), Kathelijn Keymolen (Organiser), Ken Maes (Organiser), Pieter Verdyck (Organiser), Veerle Berckmoes (Organiser), Kim Van Berkel (Organiser), Frederik Jan Hes (Chair), Florence Belva (Participant), Marleen Carlé (Participant), Aranza Cortes Jauregui (Participant), Pascale De Becker (Participant), Jacques De Grève (Participant), Martine De Rycke (Chair), Elke De Schutter (Participant), Simon Denil (Participant), Boyan Dimitrov (Participant), Elia Fernandez Gallardo (Participant), Annelies Fieuw (Participant), Alexander Gheldof (Participant), Philippe Giron (Participant), Ingeborg Liebaers (Member of programme committee), Eva Sammels (Participant), Sara Seneca (Participant), Ileen Slegers (Participant), Katrien Stouffs (Chair), Sophie Uyttebroeck (Participant), Annelore Van Der Kelen (Participant), Andre Van Steirteghem (Member of programme committee), Elise Vantroys (Participant)17 Sep 2021Activity: Participating in or organising an event › Participating in or organizing an event at an external academic organisation
-
Targeting of pyrroline-5-carboxylate reductase (PYCR) reduces drug resistance in multiple myeloma in vitro.
Inge Oudaert (Speaker), Eline Menu (Contributor), Kim De Veirman (Contributor)29 Jan 2021 → 30 Jan 2021Activity: Talk or presentation › Talk or presentation at a conference